Palliative cancer patients pain reduction methods during opioid epidemic era
DOI:
https://doi.org/10.12775/JEHS.2022.12.12.030Keywords
cancer patients, cancer patients and opioids, pain and cancer, chronic pain, palliative cancerAbstract
Introduction: Opioids are the most commonly used medication in palliative cancer pain treatment due to their proven effectiveness. However, modern anti-pain treatment concentrates not only on analgesics, but simultaneously on the detection of conditions affecting and intensifying pain sensation. Many studies have shown potential of other, non-opioidal palliative cancer pain treatment with additional positive effect on patient’s general quality of life.
Aim of the study: The purpose of our review is to introduce the issue of the use of opioids and draw attention to other non-opioidal pain reduction methods as well as to indicate directions for further potential researches.
Methods and materials: We have reviewed the literature available in the PubMed, Google Scholar, Science Direct database using the keywords: „cancer patients and opioids”; „pain and cancer”; „chronic pain”; „palliative cancer”. We excluded abstracts, comments, and non–English language articles.
Results:
The methods outlined in this review will not affect pain reduction to the same extent as opioids, but they offer a chance to reduce it to a level that allows patients to maintain a normal life. In the light of opioid epidemic era literature shows new approaches to treating pain such as analgesics, including antidepressants, anticonvulsants, Vitamins, cannabis and nonpharmacological methods and showing their potential for wider use in palliative cancer patients treatment.
Conclusion: Besides opioids, there are many factors that affect pain reduction, however, their analgesic potential require additional studies on larger groups of patients.
References
Merskey H, Bugduk N. Classification of Chronic Pain. Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd Ed. IASP Press, Seattle, WA. 1994.
Te Boveldt N, Vernooij-Dassen M, Burger N, et al.. Pain and its interference with daily activities in medical oncology outpatients. Pain Physician 2013;16:379–389. PMID: 23877454.
Grudzen CR, Richardson LD, Johnson PN, et al. Emergency Department-Initiated Palliative Care in Advanced Cancer: A Randomized Clinical Trial. JAMA Oncol. 2016 May 1;2(5):591-598. doi: 10.1001/jamaoncol.2015.5252. PMID: 26768772; PMCID: PMC9252442.
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007 Sep;18(9):1437-49. doi: 10.1093/annonc/mdm056. Epub 2007 Mar 12. PMID: 17355955.
Bennett M, Paice JA, Wallace M. Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives. Am Soc Clin Oncol Educ Book. 2017;37:705-713. doi: 10.1200/EDBK_180469. PMID: 28561731.
Hjermstad MJ, Kaasa S, Caraceni A, et al; European Palliative Care Research Collaborative (EPCRC). Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer. BMJ Support Palliat Care. 2016 Sep;6(3):344-52. doi: 10.1136/bmjspcare-2015-000887. Epub 2016 Jun 24. PMID: 27342412.
Hernandez MA, Rathinavelu A. Basic Pharmacology: Understanding Drug Actions and Reactions: Boca Raton, FL: CRC Press; 2017.
Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin. 2018 May;68(3):182-196. doi: 10.3322/caac.21453. Epub 2018 Mar 30. PMID: 29603142; PMCID: PMC5980731.
Ganguly A, Michael M, Goschin S, et al. Cancer Pain and Opioid Use Disorder. Oncology (Williston Park). 2022 Sep 7;36(9):535-541. doi: 10.46883/2022.25920973. PMID: 36107782.
Gibbins J, Bhatia R, Forbes K, et al. What do patients with advanced incurable cancer want from the management of their pain? A qualitative study. Palliat Med. 2014 Jan;28(1):71-8. doi: 10.1177/0269216313486310. Epub 2013 May 13. PMID: 23670721.
Jacqueline L. Bender, Joanne Hohenadel, Jennifer Wong, et al. What Patients with Cancer Want to Know About Pain: A Qualitative Study, Journal of Pain and Symptom Management, Volume 35, Issue 2, 2008, Pages 177-187, ISSN 0885-3924, https://doi.org/10.1016/j.jpainsymman.2007.03.011.
Krebber AM, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. 2014 Feb;23(2):121-30. doi: 10.1002/pon.3409. Epub 2013 Sep 16. PMID: 24105788; PMCID: PMC4282549.
Newport DJ, Nemeroff CB. Assessment and treatment of depression in the cancer patient. J Psychosom Res. 1998 Sep;45(3):215-37. doi: 10.1016/s0022-3999(98)00011-7. PMID: 9776368
Bair MJ, Robinson RL, Katon W, et al. Depression and Pain Comorbidity: A Literature Review. Arch Intern Med. 2003;163(20):2433–2445. doi:10.1001/archinte.163.20.2433
Lachlan A. McWilliams, Renee D. Goodwin, Brian J. Cox,
Fasick V, Spengler RN, Samankan S, Nader ND, Ignatowski TA. The hippocampus and TNF: Common links between chronic pain and depression. Neurosci Biobehav Rev. 2015 Jun;53:139-59. doi: 10.1016/j.neubiorev.2015.03.014. Epub 2015 Apr 7. PMID: 25857253.
Yoon SY, Oh J. Neuropathic cancer pain: prevalence, pathophysiology, and management. Korean J Intern Med. 2018 Nov;33(6):1058-1069. doi: 10.3904/kjim.2018.162. Epub 2018 Jun 25. PMID: 29929349; PMCID: PMC6234399.
Bennett MI, Rayment C, Hjermstad M, et al. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain. 2012 Feb;153(2):359-365. doi: 10.1016/j.pain.2011.10.028. Epub 2011 Nov 23. PMID: 22115921.
Hershman DL, Lacchetti C, Dworkin RH, et al. American Society of Clinical Oncology. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14. PMID: 24733808.
Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014 Dec;155(12):2461-2470. doi: 10.1016/j.pain.2014.09.020. Epub 2014 Sep 23. PMID: 25261162.
Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010 Aug;9(8):807-19. doi: 10.1016/S1474-4422(10)70143-5. PMID: 20650402.
McCleane G. Antidepressants as analgesics. CNS Drugs. 2008;22(2):139-56. doi: 10.2165/00023210-200822020-00005. PMID: 18193925.
Moore RA, Derry S, Aldington D, et al. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev. 2015 Jul 6;2015(7):CD008242. doi: 10.1002/14651858.CD008242.pub3. PMID: 26146793; PMCID: PMC6447238.
Accordino MK, Neugut AI, Hershman DL. Cardiac effects of anticancer therapy in the elderly. J Clin Oncol. 2014 Aug 20;32(24):2654-61. doi: 10.1200/JCO.2013.55.0459. Epub 2014 Jul 28. PMID: 25071122; PMCID: PMC4876340.
Duman EN, Kesim M, Kadioglu M, Yaris E, Et al. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J Pharmacol Sci. 2004 Feb;94(2):161-5. doi: 10.1254/jphs.94.161. PMID: 14978354.
Schreiber S, Pick CG. From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram. Eur Neuropsychopharmacol. 2006 Aug;16(6):464-8. doi: 10.1016/j.euroneuro.2005.11.013. Epub 2006 Jan 18. PMID: 16413173.
Smith EM, Pang H, Cirrincione C, et al. Alliance for Clinical Trials in Oncology. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA. 2013 Apr 3;309(13):1359-67. doi: 10.1001/jama.2013.2813. PMID: 23549581; PMCID: PMC3912515.
Kus T, Aktas G, Alpak G, et al. Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case-control study. Support Care Cancer. 2016 May;24(5):2085-2091. doi: 10.1007/s00520-015-3009-x. Epub 2015 Nov 7. PMID: 26546457.
Raptis E, Vadalouca A, Stavropoulou E, et al. Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study. Pain Pract. 2014 Jan;14(1):32-42. doi: 10.1111/papr.12045. Epub 2013 Mar 6. PMID: 23464813.
Mishra, Seema, et al. "A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study." American Journal of Hospice and Palliative Medicine® 29.3 (2012): 177-182.
Rao RD, Michalak JC, Sloan JA, et al; North Central Cancer Treatment Group. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer. 2007 Nov 1;110(9):2110-8. doi: 10.1002/cncr.23008. PMID: 17853395.
Hershman DL, Lacchetti C, Dworkin RH, et al; American Society of Clinical Oncology. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14. PMID: 24733808.
Bergman P, Sperneder S, Höijer J, Bergqvist J, et al. Low vitamin D levels are associated with higher opioid dose in palliative cancer patients--results from an observational study in Sweden. PLoS One. 2015 May 27;10(5):e0128223. doi: 10.1371/journal.pone.0128223. PMID: 26018761; PMCID: PMC4446094.
Helde Frankling M, Klasson C, Sandberg C, et al. 'Palliative-D'-Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial. Cancers (Basel). 2021 Jul 23;13(15):3707. doi: 10.3390/cancers13153707. PMID: 34359609; PMCID: PMC8345220.
Dev R, Del Fabbro E, Schwartz GG, et al. Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia. Oncologist. 2011;16(11):1637-41. doi: 10.1634/theoncologist.2011-0151. Epub 2011 Sep 30. PMID: 21964001; PMCID: PMC3233299.
Shi L, Nechuta S, Gao YT,et al. Correlates of 25-hydroxyvitamin D among Chinese breast cancer patients. PLoS One. 2014 Jan 21;9(1):e86467. doi: 10.1371/journal.pone.0086467. PMID: 24466109; PMCID: PMC3897707.
Ward SJ, McAllister SD, Kawamura R, et al. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy. Br J Pharmacol. 2014 Feb;171(3):636-45. doi: 10.1111/bph.12439. PMID: 24117398; PMCID: PMC3969077.
Deng L, Guindon J, Cornett BL, et al. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal. Biol Psychiatry. 2015 Mar 1;77(5):475-87. doi: 10.1016/j.biopsych.2014.04.009. Epub 2014 Apr 25. PMID: 24853387; PMCID: PMC4209205.
Huang WJ, Chen WW, Zhang X. Endocannabinoid system: Role in depression, reward and pain control (Review). Mol Med Rep. 2016 Oct;14(4):2899-903. doi: 10.3892/mmr.2016.5585. Epub 2016 Aug 1. PMID: 27484193; PMCID: PMC5042796.
Boehnke KF, Litinas E, Clauw DJ. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. J Pain. 2016 Jun;17(6):739-44. doi: 10.1016/j.jpain.2016.03.002. Epub 2016 Mar 19. PMID: 27001005.
Abrams DI, Jay CA, Shade SB, Et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007 Feb 13;68(7):515-21. doi: 10.1212/01.wnl.0000253187.66183.9c. PMID: 17296917.
41. Pan CX, Morrison RS, Ness J, Et al. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manage. 2000 Nov;20(5):374-87. doi: 10.1016/s0885-3924(00)00190-1. PMID: 11068159.
Cramer H, Lauche R, Paul A, et al. Hypnosis in breast cancer care: a systematic review of randomized controlled trials. Integr Cancer Ther. 2015 Jan;14(1):5-15. doi: 10.1177/1534735414550035. Epub 2014 Sep 18. PMID: 25233905.
Rajasekaran M, Edmonds PM, Higginson IL. Systematic review of hypnotherapy for treating symptoms in terminally ill adult cancer patients. Palliat Med. 2005 Jul;19(5):418-26. doi: 10.1191/0269216305pm1030oa. PMID: 16111066.
Sheinfeld Gorin S, Krebs P, Badr H, Et al. Meta-analysis of psychosocial interventions to reduce pain in patients with cancer. J Clin Oncol. 2012 Feb 10;30(5):539-47. doi: 10.1200/JCO.2011.37.0437. Epub 2012 Jan 17. PMID: 22253460; PMCID: PMC6815997.
Butler LD, Koopman C, Neri E, Et al. Effects of supportive-expressive group therapy on pain in women with metastatic breast cancer. Health Psychol. 2009 Sep;28(5):579-87. doi: 10.1037/a0016124. PMID: 19751084.
Vickers AJ, Linde K. Acupuncture for chronic pain. JAMA. 2014 Mar 5;311(9):955-6. doi: 10.1001/jama.2013.285478. PMID: 24595780; PMCID: PMC4036643.
Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture Trialists' Collaboration. Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis. J Pain. 2018 May;19(5):455-474. doi: 10.1016/j.jpain.2017.11.005. Epub 2017 Dec 2. PMID: 29198932; PMCID: PMC5927830.
Sawynok J. Adenosine receptor targets for pain. Neuroscience. 2016 Dec 3;338:1-18. doi: 10.1016/j.neuroscience.2015.10.031. Epub 2015 Oct 21. PMID: 26500181.
Lee JH. The Effects of Music on Pain: A Meta-Analysis. J Music Ther. 2016 Winter;53(4):430-477. doi: 10.1093/jmt/thw012. Epub 2016 Oct 19. Erratum in: J Music Ther. 2021 Aug 24;58(3):372. PMID: 27760797.
Bradt J, Dileo C, Magill L, Teague A. Music interventions for improving psychological and physical outcomes in cancer patients. Cochrane Database Syst Rev. 2016 Aug 15;(8):CD006911. doi: 10.1002/14651858.CD006911.pub3. Update in: Cochrane Database Syst Rev. 2021 Oct 12;10:CD006911. PMID: 27524661.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Natalia Sobańska, Katarzyna Bednarz, Patryk Banaś, Aleksandra Paulina Banasiak, Rafał Teichman, Jakub Kasprowicz, Jakub Rafał Pierzchała, Kamila Abram, Justyna Adamus, Michał Hyjek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 374
Number of citations: 0